Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-26

Clinical Trial Update: Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema [Phase 3]

View source ↗

Summary

Phase 3 trial comparing alitretinoin to cyclosporine in severe recurrent vesicular hand eczema is ongoing or has unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alitretinoin (alitretinoin)
  • CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Hand Eczema | Phase 3 | Status: UNKNOWN